The endometrium – from estrogens alone to TSECs
Author:
- 11 November 2009
- journal article
- review article
- Published by Taylor & Francis in Climacteric
- Vol. 12 (6) , 463-477
Abstract
This article reviews publications dating back more than a century describing investigations of the endometrium, including those examining the relationship between endometrial hyperplasia and carcinoma, the influence of estrogens on the endometrium, and strategies for protecting the endometrium from unopposed estrogen stimulation. Endometrial hyperplasia and carcinoma studies date from before 1900. The influence of endogenous estrogens on the endometrium became evident with observations of endometrial hyperplasia and/or carcinoma in women with estrogen-secreting tumors or polycystic ovarian disease. Later, observational studies and randomized, controlled trials suggested a relationship between unopposed estrogens and endometrial cancer and hyperplasia. The first, and to date only, effective clinical strategy for protecting the endometrium from unopposed estrogen stimulation has been the use of progestins. A new approach for endometrial protection in menopausal therapy is the pairing of a selective estrogen receptor modulator (SERM) with estrogen(s), also known as a tissue selective estrogen complex (TSEC). Effective protection of the endometrium as well as treatment of menopausal symptoms and prevention of osteoporosis would be key elements for a clinically useful TSEC.Keywords
This publication has 76 references indexed in Scilit:
- Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC)Endocrine-Related Cancer, 2008
- Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal womenInternational Journal of Cancer, 2003
- Case--Control Study of Endogenous Steroid Hormones and Endometrial CancerJNCI: Journal of the National Cancer Institute, 1996
- Risk of Localized and Widespread Endometrial Cancer in Relation to Recent and Discontinued Use of Conjugated EstrogensNew England Journal of Medicine, 1985
- Progestin therapy in endometrial hyperplasiaGynecologic Oncology, 1974
- Irregular Hyperplasias of the EndometriumActa Obstetricia et Gynecologica Scandinavica, 1957
- Association of Certain Ovarian Cells with Endometrial CancerBMJ, 1949
- Corpus cancer.Clinical, pathological, and etiological aspectsCancer, 1948
- Medical Aspects of ObstetricsNew England Journal of Medicine, 1942
- Zur Aetiologie der “Endometritis fungosa”, speciell der “chronischen hyperplasirenden Endometritis Olshausen's”Archives of Gynecology and Obstetrics, 1882